论文部分内容阅读
目的：探讨宫颈粘液腺癌的临床特点及其治疗方法。方法：本文对1958年至1990年我院收治的41例宫颈粘液腺癌的临床资料进行回顾性分析。结果：宫颈粘液腺癌占同期宫颈腺癌的19．16（41／214）。平均年龄为50．89岁，阴道白带增多为临床突出症状，按FIGO分期，Ⅱ期占34．14％（14／41），Ⅲ期占56．09％（23／41），Ⅳ期占9．76％（4／41）。采用单纯放疗26例，综合治疗15例。总5年生存率为13．20％，其中Ⅱ期33.30％，Ⅲ期2．17％，Ⅳ期0.宫颈直径≤3cm和＞3cm5年生存率分别为9．09％和12.80％（P＞0．05）。结论：本资料表明宫颈粘液腺癌的预后比宫颈鳞癌以及其他类型的宫颈腺癌差，与临床分期有关，但与宫颈肿瘤大小无关。
Objective: To investigate the clinical features and treatment of cervical mucinous adenocarcinoma. Methods: The clinical data of 41 cases of cervical mucinous adenocarcinoma treated in our hospital from 1958 to 1990 were retrospectively analyzed. Results: Cervical mucinous adenocarcinoma accounted for 19.16 (41/214) of cervical adenocarcinoma in the same period. The average age was 50.89 years. Vaginal leucorrhea increased clinically. According to FIGO stage, stage II accounted for 34.14% (14/41), stage III accounted for 56.09% (23/41), stage IV accounted for 9 .76% (4/41). 26 cases were treated with radiotherapy alone and 15 cases were treated comprehensively. The overall 5-year survival rate was 13.20%, of which stage 33.30%, phase III 2.17%, stage IV. Cervical diameter ≤3cm and>3cm 5-year survival rates were 9.09% and 12.80%, respectively (P> 0.05). Conclusion: This data shows that the prognosis of cervical mucinous adenocarcinoma is worse than that of cervical squamous cell carcinoma and other types of cervical adenocarcinoma, and is related to clinical stage, but not to the size of cervical tumor.